A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2009
12/29/2009	CA2423296C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists
12/29/2009	CA2415683C Indoloquinazolinones
12/29/2009	CA2411760C 2-aminothiazoline derivatives and their use as no-synthase inhibitors
12/29/2009	CA2384624C Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
12/29/2009	CA2348993C Substituted phenethylsulfones and method of reducing tnf.alpha. levels
12/24/2009	US20090318882 Intraosseous dental anesthesia
12/24/2009	US20090318564 Process for preparing and drying solid rasagiline base
12/24/2009	US20090318544 Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
12/24/2009	US20090318541 such as tert-butyl [(1S)-1-benzyl-2-({2-[(hydroxyamino)carbonyl]-1-benzothien-6-yl}amino)ethyl]carbamate, exhibiting histone deacetylase inhibitory activity, used for treating cancer, autoimmune, allergic, inflammatory and neurodegenerative diseases
12/24/2009	US20090318524 Bicyclic tetrahydropyrrole compounds
12/24/2009	US20090318523 Benzoisoindole derivatives and their use as ep4 receptor agonists
12/24/2009	US20090318503 Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
12/24/2009	US20090318490 Compounds and methods for promoting smoking cessation
12/24/2009	US20090318489 Aporphine compounds and pharmaceutical use thereof
12/24/2009	US20090318486 Tricyclic spiro derivatives as CRTH2 modulators
12/24/2009	US20090318484 Inhibitors of JNK
12/24/2009	US20090318483 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist;
12/24/2009	US20090318470 1-substituted-3-(naphthalen-1-ylsulfonyl)-5-(piperazin-1-yl)-1h-indazole compounds as 5-hydroxytryptamine-6 ligands
12/24/2009	US20090318452 INHIBITORS OF p38
12/24/2009	US20090318447 N-[6-(4-morpholinyl)-3-pyridinyl]-2-(tetrahydro-2h-pyran-4-yl)-n-[(1--4-piperidinyl) methyl] acetamide derivatives and related compounds as glyt1 transport inhibitors for the treatment of neurological disorders such as schizophrenia
12/24/2009	US20090318444 Tetrahydro- and dihydroquinazolinones
12/24/2009	US20090318442 Thiazolyl-and oxazolyl-isoquinolinones and methods for using them
12/24/2009	US20090318439 5-furopyridinone substituted indazoles
12/24/2009	US20090318425 Apoptosis signal-regulating kinase 1 inhibitors
12/24/2009	US20090318424 Novel compounds
12/24/2009	US20090318415 Dibenzothiazepine derivatives and uses thereof - 424
12/24/2009	US20090318414 Mono and Combination Therapy with M1/M4 Muscarinic Agonist (Sabcomeline) for Treatment of Prodromal Syndrome
12/24/2009	US20090318406 Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands
12/24/2009	US20090318398 Androgen pharmaceutical composition and method for treating depression
12/24/2009	US20090318384 Composition intended for the treatment of amyotrophic lateral sclerosis
12/24/2009	US20090318374 Methods of diagnosing and treating migraine
12/24/2009	US20090318369 Biomarkers for alzheimer's disease and methods using the same
12/24/2009	US20090318365 Metastin derivatives and use thereof
12/24/2009	US20090318360 Use of the neurotoxic component of a botulinum toxin for treating arthritis
12/24/2009	US20090318333 Modified Metallothioneins and Methods for Screening and Treatment of Diseases Associated With Oxidative Stress
12/24/2009	US20090317463 Composition for oral use based on s-adenosylmethionine and a process for their preparation
12/24/2009	US20090317462 Peptide pharmaceutical for oral delivery
12/24/2009	US20090317398 a labeled polyclonal antibody, monoclonal antibody or antigen-binding fragment which preferentially binds to a polypeptide that chemoattracts peripheral blood monocytes or T-cells; proteins which control development, differentiation, trafficking and physiology of mammalian cells; immunology
12/24/2009	US20090317389 Fusion molecules and methods for treatment of immune diseases
12/24/2009	US20090317377 Therapy procedure for drug delivery for trigeminal pain
12/24/2009	US20090317367 Methods of producing preadipocytes and increasing the proliferation of adult adipose stem/progenitor cells
12/24/2009	US20090317364 Novel compositions for prevention and treatment of mastitis and metritis
12/24/2009	US20090317355 Abuse resistant melt extruded formulation having reduced alcohol interaction
12/24/2009	US20090317328 Tricyclic oxazepines as in vivo imaging compounds
12/24/2009	US20090317324 Filamentous bacteriophage displaying protein as a binder of antibodies and immunocomplexes for delivery to the brain
12/24/2009	DE10262084B4 Protektive Lösung zur Verhinderung von Ischämieschäden Protective solution for preventing ischemic damage
12/23/2009	WO2009155609A1 IMMUNOGENIC MEMAPSIN 2 β-SECRETASE PEPTIDES AND METHODS OF USE
12/23/2009	WO2009155488A2 Novel oxalate salt and crystal of o-desmethylvenlafaxine
12/23/2009	WO2009155448A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/23/2009	WO2009155402A1 Thiazolyl- and oxazolyl-isoquinolinones and methods for using them
12/23/2009	WO2009155399A1 1-substituted-3-(naphthalen-1-ylsulfonyl)-5-(piperazin-1-yl)-1h-indazole compounds as 5-hydroxytryptamine-6 ligands
12/23/2009	WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses
12/23/2009	WO2009155301A2 Multipotent neural cells
12/23/2009	WO2009155139A1 Use of isoindoles for the treatment of neurobehavioral disorders
12/23/2009	WO2009155055A2 Methods of effecting wnt signaling through dkk structural analysis
12/23/2009	WO2009155054A2 5-ht3 receptor modulators, methods of making, and use thereof
12/23/2009	WO2009155052A1 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/23/2009	WO2009155017A2 Novel substituted azabenzoxazoles
12/23/2009	WO2009154780A1 S1p1 receptor agonists and use thereof
12/23/2009	WO2009154777A2 Process for preparing and drying solid rasagiline base
12/23/2009	WO2009154766A1 Renin inhibitors and method of use thereof
12/23/2009	WO2009154697A2 Disc-1 pathway activators in the control of neurogenesis
12/23/2009	WO2009154645A1 Methods for the treatment of central nervous system tumors
12/23/2009	WO2009154563A1 Dibenzothiazepine derivatives and use thereof
12/23/2009	WO2009154460A1 Modulation of memory function.
12/23/2009	WO2009154230A1 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis
12/23/2009	WO2009154197A1 Cognitive disorder-ameliorating agent
12/23/2009	WO2009154169A1 Peptide derivative and composition for promoting tear secretion comprising the same
12/23/2009	WO2009154132A1 Spirodiamine-diarylketoxime derivative
12/23/2009	WO2009154041A1 Method for producing morphine
12/23/2009	WO2009153307A1 Compounds
12/23/2009	WO2009153291A1 Combination of pilocarpin and methimazol for treating charcot-marietooth disease and related disorders
12/23/2009	WO2009153182A1 Novel heteroaryl carboxamide derivatives
12/23/2009	WO2009153179A1 Pyrrolidine derivatives as nk2 receptor antagonists
12/23/2009	WO2009153029A1 Anti-prion protein antibody fragment
12/23/2009	WO2009153009A1 Taxifolin derivatives for the prophylaxis and treatment of neurological and psychiatric disorders of the central nervous system
12/23/2009	WO2009152825A1 Novel phenylimidazole derivatives as pde10a enzyme inhibitors
12/23/2009	WO2009152777A1 A stable and release-controlled rasagiline transdermal patch and method of preparation thereof
12/23/2009	WO2009152724A1 Use of paederosidic acid methyl ester in manufacture of medicaments for treating pain and/or inflammation.
12/23/2009	WO2009152684A1 Crystalline of eszopiclone, its composition, preparation and uses thereof
12/23/2009	WO2009152647A1 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent
12/23/2009	WO2009152551A1 Pharmaceutical formulation
12/23/2009	WO2009129428A3 Methods for treating post-operative effects such as spasticity and shivering with clonidine
12/23/2009	WO2009120659A3 Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents
12/23/2009	WO2009111739A3 Treatment of herpes virus related diseases
12/23/2009	WO2009087005A3 Composition comprising a nitrooxyderivative of acetaminophen and a anticonvulsant drug for the treatment of neuropathic pain
12/23/2009	WO2008083204A3 Modulation of neurogenesis by melatoninergic ligands
12/23/2009	EP2135951A1 Transgenic rodents having ngf beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins
12/23/2009	EP2135880A1 Anti-prion protein antibody fragment
12/23/2009	EP2135617A2 Amylin and amylin agonists for treating psychiatric diseases and disorders
12/23/2009	EP2135613A1 Remedy and diagnostic for mitochondrial dysfunction brain disease
12/23/2009	EP2135611A1 Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy
12/23/2009	EP2135607A1 Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders
12/23/2009	EP2135605A2 Therapeutic delivery of carbon monoxide
12/23/2009	EP2134708A1 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
12/23/2009	EP2134703A1 Amide derivatives as calcium channel blockers
12/23/2009	EP2134701A1 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives
12/23/2009	EP2134690A1 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators
12/23/2009	EP2134688A1 Fluorinated derivatives of deferiprone
12/23/2009	EP2134687A1 Piperazine and piperidine mglur5 potentiators

1 ... 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 ... 1833